Evidence map›Paper›PMID 29602774›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.

Abel Suárez-Fueyo, Sean J Bradley, Takayuki Katsuyama, Sarah Solomon, Eri Katsuyama, Vasileios C Kyttaris, Vaishali R Moulton, George C Tsokos

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Autoimmunity in 2018.Clinical reviews in allergy & immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abel Suárez-FueyoDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115 gtsokos@bidmc.harvard.edu afueyo@bidmc.harvard.edu.
Sean J BradleyDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.
Takayuki KatsuyamaDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.
Sarah SolomonDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.
Eri KatsuyamaDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.
Vasileios C KyttarisDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.ORCID 0000-0001-7652-3826
Vaishali R MoultonDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115.
George C TsokosDivision of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115 gtsokos@bidmc.harvard.edu afueyo@bidmc.harvard.edu.ORCID 0000-0001-9589-2360
Beth Israel Deaconess Medical Center · US

Funding

LYMPHOCYTE SIGNALING DEFECTS IN PATIENTS WITH LUPUSR01AI042269 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI TSOKOS, GEORGE C · 1998 to 2017
$6.8M
Role of splicing factor SRSF1 in T cell function and autoimmunityR01AR068974 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ADAMOPOULOS, IANNIS ELIAS · 2016 to 2020
$2.2M
The Role of Interleukin 23 in LupusR01AR060849 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KYTTARIS, VASILEIOS CHRISTOS · 2012 to 2016
$1.9M
Training Program in Systemic AutoimmunityT32AI074549 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TSOKOS, GEORGE C · 2008 to 2018
$1.4M
Role and regulation of the splicing factor ASF/SF2 in human T lymphocyte physioloK01AR060781 · NIAMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MOULTON, VAISHALI · 2012 to 2016
$587k
NIAID NIH HHS R01 AI042269NIAID NIH HHS T32 AI074549NIAMS NIH HHS K01 AR060781NIAMS NIH HHS R01 AR060849NIAMS NIH HHS R01 AR068974
6 · The paper itself

Abstract

Cytotoxic function and cytokine profile of NK cells are compromised in patients with systemic lupus erythematosus (SLE). CD3ζ, an important molecule for NK cell activation, is downregulated in SLE T cells and contributes to their altered function. However, little is known about the role of CD3ζ in SLE NK cells. We studied CD3ζ levels and its contribution to cytotoxic, degranulation, and cytokine production capacity of NK cells from patients with SLE. Furthermore, we studied the human NK cell line, NKL, in which manipulation of CD3ζ levels was achieved using small interfering RNA and NK cells from

Indexed as

AnimalsCD3 ComplexDown-RegulationFemaleHumansKiller Cells, NaturalLupus Erythematosus, SystemicLymphocyte ActivationMicePhenotypeCD3 antigen, zeta chainCD3 Complex

Identifiers

PMID29602774
PMCPMC6048443
OpenAlexW2795085892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.